We are live on ! Find out more
HAO icon

Haoxi Health Technology Ltd

3 hedge funds and large institutions have $154K invested in Haoxi Health Technology Ltd in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.72% more ownership

Funds ownership: 3.99%5.71% (+1.7%)

0% more funds holding

Funds holding: 33 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

52% less capital invested

Capital invested by funds: $319K → $154K (-$165K)

Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

HAO Hedge Fund Activity: Q1 2025 in Review

3 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Haoxi Health Technology Ltd (HAO) for Q1 2025, worth a combined $154K — down 52% from $319K a quarter earlier.

Fund positioning in HAO was balanced in Q1 2025: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Boothbay Fund Management, opening a new position worth an estimated $77.1K. The largest seller was DGS Capital Management, exiting entirely with an estimated $5.75K sold.

  • 3 institutional investors held Haoxi Health Technology Ltd (HAO) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $154K of Haoxi Health Technology Ltd stock for Q1 2025, down 52% quarter-over-quarter.
  • 1 fund opened new Haoxi Health Technology Ltd positions in Q1 2025 and 1 closed out, a net change of 0 holders.
  • The largest Haoxi Health Technology Ltd buyer in Q1 2025 was Boothbay Fund Management, an estimated $77.1K added.
  • The largest Haoxi Health Technology Ltd seller in Q1 2025 was DGS Capital Management, an estimated $5.75K sold.

Based on aggregated 13F filings for Q1 2025.